The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period

Journal of Epidemiology and Community Health

Volumn 65, Issue 2, 2011, Pages 157-159

  Ting, S C H ^a   Crooks, S W ^a   South, G ^a  

^a CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; INFLUENZA VACCINE;

AGE STRUCTURE; COHORT ANALYSIS; DISEASE SEVERITY; INFLUENZA; PRIMARY HEALTH CARE; PUBLIC HEALTH; SEX DETERMINATION; VACCINATION;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; COMORBIDITY; COMPARATIVE STUDY; CONTROL GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; MEDICAL RECORD; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; SEX RATIO; SPIROMETRY; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; COMORBIDITY; CONTROL GROUPS; ENGLAND; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; INFLUENZA VACCINES; MALE; MEDICAL RECORDS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPIROMETRY; TREATMENT OUTCOME;

DERBYSHIRE; ENGLAND; UNITED KINGDOM;

EID: 78651334927     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.092296     Document Type: Article

References (9)

1. COPD. National clinical guidelines on management of COPD in adults in primary and secondary care. Thorax 2004;59(Suppl 1):15.
2. British Thoracic Society. The burden of lung disease. 2nd edn. London: BTS, 2006.
3. GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report Bethesda: NHLBI, 2001.
4. Wongsurakiat P, Nanta Maranetra K, Wasi C, et al. Acute respiratory Illness in patients with COPD and the effectiveness of influenza vaccination. Chest 2004;125:2011-20.
5. National Institute for Health and Clinical Excellence. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza. UK: National Institute for Health and Clinical Excellence, 2008.
6. European Centre For Disease Prevention and Control. Guidance: Primary Risk Groups for Influenza Vaccination. Stockholm: ECDC SIIP Team, 2008.
7. Poole P, Chacko EE, Wood-Baker R, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006; Issue 1: Art. No.: CD002733. doi:10.1002/14651858. CD002733.pub2.
8. Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003;58:835-9.
9. Telford R, Rogers A. What influences elderly peoples' decisions about whether to accept the influenza vaccination? A qualitative study. Health Educ Res 2003;18:743-53.